Bone marrow aspirates were collected under FHCRC IRB protocol 0999.209, with consent obtained for use of left-over specimens for research purposes. The material was deidentified prior to being provided for research use. The collected aspirates were washed twice in 1× PBS, Ficoll fractionated and the mononuclear cell fraction collected. Enrichment for CD34+ cells was done by magnetic bead isolation using the CD34 MicroBead Kit (Miltenyi Biotec). CD34+ HSPCs were grown in StemSpan SFEM II (Stemcell Technologies) supplemented with the following growth factor cocktails: expansion (SCF 100 ng/mL, FLT-3 ligand 10 ng/mL, TPO 100 ng/mL, IL-6 20 ng/mL), erythroid (SCF 20 ng/mL, IL-3 10 ng/mL, and EPO 4 U/mL), myeloid (SCF 100 ng/mL, FLT-3 ligand 10 ng/mL, IL-3 20 ng/mL, IL-6 20 ng/mL, GM-CSF 20 ng/mL, M-CSF 20 ng/mL, and G-CSF 20 ng/mL), megakaryocyte (SCF 10 ng/mL, IL-6 20 ng/mL, IL-9 12.5 ng/mL, and TPO 100 ng/mL). EPO was purchased from PeproTech and all other cytokines were purchased from Shenandoah Biotechnology.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.